1st Counsel – Lifestyle
Author:
ENDRA Life Sciences, Inc. (Nasdaq: NDRA)
Favorable Results on Liver Device for Long-Term Monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease Affecting 30% of Adults: ENDRA Life Sciences (Nasdaq: NDRA)
March 9, 2026